Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10271-2 | PD 98059 | LSM-3394 |  | 4713 | |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10268-1 | Nutlin 3a | LSM-6351 |  | 11433190 | |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10266-1 | NSC 663284 | LSM-2042 |  | 379077 | |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 |  | 126941 |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10262-1 | L-779450 | LSM-4283 |  | 9950176 | |
| 10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 |  | 216344 |
| 10260-1 | Ispinesib | SB-715992 | LSM-5732 |  | 6851740 |
| 10259-1 | ICRF-193 | LSM-4280 |  | 115150 | |
| 10258-1 | Ibandronate | Boniva | LSM-4279 |  | 44828485 |
| 10257-1 | GSK923295 | LSM-4278 |  | 68651179 | |
| 10255-1 | GSK1838705A | LSM-4276 |  | 25182616 | |
| 10253-1 | Glycyl-H-1152 | LSM-4274 |  | ||
| 10252-1 | Gemcitabine | Gemzar | LSM-5333 |  | 60750 |
| 10251-1 | Fascaplysin | LSM-4272 |  | 73293 | |
| 10250-1 | Etoposide | LSM-6348 |  | 36462 | |
| 10249-1 | Epirubicin | Ellence | LSM-2078 |  | 41867 |
| 10248-1 | Doxorubicin | Adriamycin | LSM-4062 |  | 31703 |
| 10247-1 | Docetaxel | Taxotere | LSM-6360 |  | 148124 |
| 10246-1 | CPT-11 | Irinotecan | LSM-2167 |  | 60838 |
| 10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 |  |